Tetroxoprim

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tetroxoprim
Tetroxoprim.svg
Systematic (IUPAC) name
5-[3,5-Dimethoxy-4-(2-methoxyethoxy)benzyl]pyrimidine-2,4-diamine
Clinical data
Legal status
?
Identifiers
CAS number 53808-87-0 YesY
ATC code J01EE06 (with sulfadiazine)
PubChem CID 65450
ChemSpider 58910 N
UNII 5R6712AY0K N
KEGG D06097 YesY
ChEMBL CHEMBL32039 N
Chemical data
Formula C16H22N4O4 
Mol. mass 334.70 g/mol
 N (what is this?)  (verify)

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.[1]

References[edit]

  1. ^ Aschhoff HS, Vergin H (November 1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother 5 (B): 19–25. doi:10.1093/jac/5.supplement_b.19. PMID 43863.